Predicting solvent and aggregation effects of peptides using group contribution calculations

Biotechnology Progress

Volumn 22, Issue 2, 2006, Pages 605-608

  Kim, Jin Ryoun ^a,b   Gibson, Todd J ^a,c   Murphy, Regina M ^a  

^a University of Wisconsin Madison   (United States)

^b Johns Hopkins University   (United States)

^c CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; BIOTECHNOLOGY; OLIGOMERS; PROTEINS; SOLVENTS; TISSUE;

ALZHEIMER'S DISEASE; AMYLOID FIBRILS; INFINITE DILUTION ACTIVITY COEFFICIENTS; SOLVENT SURFACE TENSION;

POLYPEPTIDES;

PEPTIDE; SOLVENT;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; MOLECULAR SEQUENCE DATA; PEPTIDES; SOLVENTS;

EID: 33646049045     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp050407d     Document Type: Article

References (15)

1. DeFelice, F. G.; Ferreira, S. T. Beta-amyloid production, aggregation, and clearance as targets for therapy in Alzheimer's disease. Cell. Mol. Neurobiol. 2004, 22, 545-563.
2. Pallitto, M. M.; Murphy, R. M. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys. J. 2001, 38, 1805-1822.
3. Kirkitadze, M. D.; Bitan, G.; Teplow, D. B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 2002, 69, 567-577.
4. Kayed, R.; Head, E.; Thompson, J. L.; McIntire, T. M.; Milton, S. C.; Cotman, C. W.; Glabe, C. C. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300, 486-489.
5. 6. Biophys. J. 2004, 86, 3194-3203.
6. Lowe, T. L.; Strzelec, A.; Kiessling, L. L.; Murphy, R. M. Structure-function relationships for inhibitors of beta-amyloid toxicity containing the recognition sequence KLVFF. Biochemistry 2001, 40, 7882-7889.
7. Kim, J. R.; Gibson, T. J.; Murphy, R. M. Targeted control of kinetics of beta-amyloid self-association by surface tension-modifying peptides. J. Biol. Chem. 2003, 278, 40730-40735.
8. Gibson, T. J.; Murphy, R. M. Design of peptidyl compounds that affect beta-amyloid aggregation: importance of surface tension and context. Biochemistry 2005, 44, 8898-8907.
9. Cacace, M. G.; Landau, E. M.; Ramsden, J. J. The Hofmeister series: Salt and solvent effects on interfacial phenomena. Quart. Rev. Biophys. 1997, 30, 241-277.
10. Davis-Searles, P. R.; Saunders, A. J.; Erie, D. A.; Winzor, D. J.; Pielak, G. J. Interpreting the effects of small uncharged solutes on protein-folding equilibria. Annu. Rev. Biophys. Biomol. Struct. 2001, 30, 271-306.
11. Ninni, L.; Meirelles, A. J. A. Water activity, pH and density of aqueous amino acids solutions. Biotechnol. Prog. 2001, 17, 703-711.
12. Pinho, S. P.; Silva, C. M.; Macedo, E. A. Solubility of amino acids: a group-contribution model involving phase and chemical equilibria. Ind. Eng. Chem. Res. 1994, 33, 1341-1347.
13. Agena, S. M.; Bogle, I. D. L.; Pessoas, F. L. P. An activity coefficient model for proteins. Biotechnol. Bioeng. 1997, 55, 65-71.
14. Agena, S. M.; Pusey, M. L.; Bogle, I. D. L. Protein solubility modeling. Biotechnol. Bioeng. 1999, 64, 144-150.
15. Pazuki, G. R.; Nikookar, M. A new local composition model for predicting activity coefficient and solubility of amino acids and peptides in water. Biochem. Eng. J. 2006, 28, 44-49.